July 11 (Reuters) - Prescient Therapeutics Ltd PTX.AX :
* INITIATES PHASE 1B CLINICAL TRIAL FOR FIRST-IN -CLASS ANTI-CANCER DRUG PTX-100 IN PATIENTS WITH MULTIPLE CANCERS
July 11 (Reuters) - Prescient Therapeutics Ltd PTX.AX :
* INITIATES PHASE 1B CLINICAL TRIAL FOR FIRST-IN -CLASS ANTI-CANCER DRUG PTX-100 IN PATIENTS WITH MULTIPLE CANCERS